Back to Journals » Infection and Drug Resistance » Volume 16

Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report

Total article views   HTML views PDF downloads Totals
2,512 Dovepress* 2,386+ 61 2,447
PubMed Central* 126 45 171
Totals 2,512 106 2,618
*Since 26 April 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar